June 29, 2026

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Promising Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust revenue growth and potential upside, all while navigating the complexities of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 17.96% Upside Potential for Investors

Investors looking for opportunities in the healthcare sector might find IQVIA Holdings, Inc. (NYSE: IQV) an intriguing prospect. With a market capitalization of $31.9 billion, IQVIA is a key player..

Regencell Bioscience Holdings (RGC): Navigating Volatility in the Healthcare Sector

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is carving out a niche in the healthcare sector with a focus on neurocognitive disorders,..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Healthcare Powerhouse with a 6.77% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector, continues to capture investor interest with its advanced cardiovascular solutions. With a market capitalization of $52.27 billion, the..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Ups and Downs of a Genomics Leader

Illumina, Inc. (NASDAQ: ILMN) is a heavyweight in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $26.71 billion, the company is a..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Capturing 24.84% Potential Upside in Healthcare Innovation

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry with a market capitalization of $4.28 billion...

Medtronic plc (MDT) Stock Analysis: Exploring a 21% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the healthcare sector specializing in medical devices, continues to draw investor attention with its diverse portfolio and robust financial metrics. Headquartered in Galway,..

BrightSpring Health Services, I (BTSG): Strong Buy Ratings Signal Investor Confidence Despite Valuation Challenges

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector with its robust platform offering home and community-based healthcare services. Operating primarily in the United States, BrightSpring provides..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a 48.89% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology sector with a focus on developing therapies for rare and life-threatening diseases. With a current market capitalization of $11.4 billion,..

Tenet Healthcare Corporation (THC) Stock Analysis: Unlocking a 28.67% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Tenet Healthcare Corporation (NYSE: THC) presents a compelling case. With a potential upside of 28.67% based on current analyst ratings, Tenet Healthcare..

Sanofi (SNY) Stock Analysis: A Compelling 30% Upside Potential Amidst Strong Dividend Yield

Sanofi (NASDAQ: SNY), a stalwart in the global healthcare sector, continues to capture investor attention with its robust dividend yield and promising growth potential. With a market capitalization of $102.81..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a Promising 50% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry, with its innovative cardiac monitoring solutions. As a digital healthcare company..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech with Promising Upside and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline focused on rare neuroendocrine diseases. With a current market capitalization of..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 32% Upside Opportunity in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, offers investors a compelling opportunity with a potential upside of 32.39%. Specializing in novel therapeutics for metabolic dysfunction-associated..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Navigating a 15.35% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) is capturing investor attention with a compelling upside potential of 15.35%, positioning itself as a promising player in the healthcare sector, specifically within the specialty and..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Amidst a Stretched Valuation

Humana Inc. (NYSE: HUM), a stalwart in the healthcare plans industry, boasts a market capitalization of $46.08 billion, marking its prominence within the United States’ healthcare sector. Despite its impressive..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.19 billion, this Texas-based company..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with a Potential 49.75% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, is making waves with its innovative RNA interference therapeutics. With a market capitalization of $38.9 billion, the company is..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 11.55% Potential Upside in the Healthcare Sector

As a key player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) stands out with its robust offerings in the diagnostics and research industry. With a market capitalization of $8.13..

Search

Funds

June 29, 2026

Search

Funds

June 29, 2026

FTSE 100

Funds